Siegfried Holding AG (XSWX:SFZN) Interest Expense : CHF-9 Mil (TTM As of Dec. 2023)

View and export this data going back to 1973. Start your Free Trial

What is Siegfried Holding AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Siegfried Holding AG's interest expense for the six months ended in Dec. 2023 was CHF -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Siegfried Holding AG's Operating Income for the six months ended in Dec. 2023 was CHF 87 Mil. Siegfried Holding AG's Interest Expense for the six months ended in Dec. 2023 was CHF -5 Mil. Siegfried Holding AG's Interest Coverage for the quarter that ended in Dec. 2023 was 17.32. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Siegfried Holding AG Interest Expense Historical Data

The historical data trend for Siegfried Holding AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siegfried Holding AG Interest Expense Chart

Siegfried Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-3.15

-2.90

-3.90

-7.60

-9.30

Siegfried Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-2.08	-2.91	-4.70	-4.30	-5.00

Siegfried Holding AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-9 Mil.

Siegfried Holding AG (XSWX:SFZN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Siegfried Holding AG's Interest Expense for the six months ended in Dec. 2023 was CHF-5 Mil. Its Operating Income for the six months ended in Dec. 2023 was CHF87 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was CHF0 Mil.

Siegfried Holding AG's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	86.675	/	-5.004
	=	17.32

The higher the ratio, the stronger the company's financial strength is.

Siegfried Holding AG (XSWX:SFZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (XSWX:SFZN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SFZNz:UK

Address

Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800

Website

https://www.siegfried.ch

Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.

Siegfried Holding AG (XSWX:SFZN) Headlines

No Headlines